Article Information
vol. 31 no. 165
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 4, 2021
- Accepted May 23, 2022
- Published online July 12, 2022.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- 1Center for Pulmonary Heart Disease, Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- 2Unità di Pneumologia e Terapia Semi-Intensiva Respiratoria, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, MultiMedica IRCCS, Milan, Italy
- 3Pulmonology Division, Lady Davis-Carmel Medical Center, Haifa, Israel
- 4Bruce and Ruth Rappaport Faculty of Medicine, The Technion, Haifa, Israel
- 5Université Paris-Saclay, INSERM UMR_S 999, Assistance Publique Hôpitaux de Paris, Department of Respiratory and Intensive Care Medicine, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
- 6Dept of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
- Corresponding author: Aaron B. Waxman (abwaxman{at}bwh.harvard.edu)
Article usage
Altmetrics
Vol 31 Issue 165
Table of Contents
Recent advances in the management of pulmonary hypertension with interstitial lung disease
Jump To
- Article
- Abstract
- Abstract
- Introduction
- Aetiology and classification
- Haemodynamic classification
- Screening and diagnostic evaluation
- The role of pulmonary function testing
- The role of echocardiography
- The role of chest computed tomography
- The role of exercise testing
- Haemodynamic assessment
- Prognosis in PH-ILD
- Pharmacological management of PH-ILD
- Pulmonary rehabilitation
- Conclusion
- Footnotes
- References
- Figures & Data
- Info & Metrics